Go Pro
→ Three companies about to leapfrog Nvidia [And transform the entire industry] (From Eagle Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.01
$0.04
▼
$0.19
$653K0.311,976 shsN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$2.55
-21.1%		$5.40
$2.26
▼
$212.10
$1.80M0.62137,657 shs740,839 shs
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
$5.93
+11.9%		$6.21
$2.40
▼
$50.40
$3.96M1.3610.64 million shs108.06 million shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$0.18
-0.9%		$0.33
$0.16
▼
$3.70
$2.52M6.0432.40 million shs1.46 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%0.00%0.00%0.00%-87.06%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-21.05%-14.43%-54.88%-56.00%-96.33%
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
+11.89%+59.41%+5.14%-72.54%-85.39%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-0.88%-3.43%-37.06%-68.53%-95.28%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.01
$0.04
▼
$0.19
$653K0.311,976 shsN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$2.55
-21.1%		$5.40
$2.26
▼
$212.10
$1.80M0.62137,657 shs740,839 shs
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
$5.93
+11.9%		$6.21
$2.40
▼
$50.40
$3.96M1.3610.64 million shs108.06 million shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$0.18
-0.9%		$0.33
$0.16
▼
$3.70
$2.52M6.0432.40 million shs1.46 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%0.00%0.00%0.00%-87.06%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-21.05%-14.43%-54.88%-56.00%-96.33%
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
+11.89%+59.41%+5.14%-72.54%-85.39%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-0.88%-3.43%-37.06%-68.53%-95.28%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
1.00
SellN/AN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
2.00
HoldN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.25
Hold$2.801,455.56% Upside

Current Analyst Ratings Breakdown

Latest DYNT, VVOS, TNON, and GCTK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2026
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.00N/AN/A$0.57 per share0.00
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A$41.93 per shareN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
$5.31M0.74N/AN/A$6.19 per share0.96
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$20.90M0.12N/AN/A($0.16) per share-1.13
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$1.35N/AN/AN/A-8.35%-41.81%-9.56%N/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-$19.39M-$137.63N/AN/AN/AN/A-2,135.52%-290.22%N/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
-$12.56M-$44.87N/AN/AN/A-257.85%-907.60%-124.84%11/12/2026 (Estimated)
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$21.17M-$1.90N/AN/AN/A-122.00%-2,325.64%-102.01%11/18/2026 (Estimated)

Latest DYNT, VVOS, TNON, and GCTK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.41-$0.31+$0.10-$0.31$5.63 million$5.15 million
8/13/2026Q2 2026
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
-$8.40-$12.35-$3.95-$12.35$1.54 million$1.28 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/AN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
N/AN/AN/AN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.08
0.46
0.46
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
N/A
0.58
0.48
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/A
0.21
0.21

Institutional Ownership

CompanyInstitutional Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
10.92%
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
22.74%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26.35%

Insider Ownership

CompanyInsider Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
2.90%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
5.90%
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
17.71%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20016.05 million8.11 millionNot Optionable
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
5706,000664,000Not Optionable
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
8667,000549,000Not Optionable
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
16013.90 million13.60 millionOptionable

Recent News About These Companies

Vivos Therapeutics Announces Material Debt Reduction
September 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/08/3357678/0/en/vivos-therapeutics-announces-material-debt-reduction.html
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference
September 1, 2026  |  newsfilecorp.comN
Vivos Therapeutics Advances South Florida Sleep Center With South Palm Cardiovascular Partnership
August 28, 2026  |  rttnews.comhttps://www.rttnews.com/3686483/vivos-therapeutics-advances-south-florida-sleep-center-with-south-palm-cardiovascular-partnership.aspx
Vivos Therapeutics Announces Definitive Agreements With South Palm Cardiovascular Associates to Launch South Florida Sleep & Airway Medicine Center
August 28, 2026  |  quiverquant.comQ
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
August 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/28/3352691/0/en/vivos-therapeutics-and-south-palm-cardiovascular-associates-sign-definitive-agreements-to-launch-regional-sleep-testing-and-treatment-center.html
Vivos Therapeutics Reports 212% Increase in Nevada Sleep & Airway Medicine Center Referrals Ahead of Henderson Facility Opening
August 25, 2026  |  quiverquant.comQ
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
August 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/25/3350463/0/en/vivos-therapeutics-reports-record-new-patient-referrals-at-its-nevada-sleep-airway-medicine-centers.html
Vivos Therapeutics Opens New Henderson Sleep Center, Expects Capacity to More Than Double to Over $10 Million Annually
August 20, 2026  |  quiverquant.comQ
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment
August 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/20/3348540/0/en/vivos-therapeutics-opens-new-sleep-testing-and-treatment-facility-in-nevada-to-meet-rapidly-growing-patient-demand-for-sleep-apnea-testing-and-treatment.html
Vivos Therapeutics shares slide after Q2 revenue falls short of forecasts
August 17, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/vivos-therapeutics-shares-slide-after-q2-revenue-falls-short-of-forecasts/ar-AA2aisUN
Vivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
August 15, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69320784-vivos-therapeutics-inc-vivos-therapeutics-reports-second-quarter-2026-financial-results-and-provides-operational-update-399.htm
Vivos Therapeutics, Inc. (VVOS) Q2 2026 Earnings Call Transcript
August 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4936959-vivos-therapeutics-inc-vvos-q2-2026-earnings-call-transcript
Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates
August 14, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2975352/vivos-therapeutics-inc-vvos-reports-q2-loss-lags-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2975352
Vivos Therapeutics Reports 35% Quarterly Revenue Growth, Rising Patient Demand and Second Quarter 2026 Results
August 14, 2026  |  quiverquant.comQ
Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
August 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/14/3345627/0/en/vivos-therapeutics-reports-second-quarter-2026-financial-results-and-provides-operational-update.html
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
August 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/14/3345341/0/en/vivos-therapeutics-schedules-release-of-second-quarter-2026-financial-results-and-conference-call.html
Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
August 11, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/vivos-therapeutics-expands-greenway-health-partnership-to-deploy-ai-enabled-platform-across-all-clinical-and-revenue-operations-1036440833
Vivos Therapeutics Expands AI Workflow Partnership with Greenway Health, Citing Up to $9.1 Million in Annual Value at Sleep Centers of Nevada
August 11, 2026  |  quiverquant.comQ
Vivos Therapeutics secures new US patent expanding protection for Vivos CARE technology
August 6, 2026  |  msn.comhttps://www.msn.com/en-us/health/medical/vivos-therapeutics-secures-new-us-patent-expanding-protection-for-vivos-care-technology/ar-AA29snYQ
Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339303/0/en/vivos-therapeutics-announces-issuance-of-new-us-patent-broadening-protection-for-its-vivos-care-oral-medical-device-technology.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

GlucoTrack stock logo

GlucoTrack NASDAQ:GCTK

$2.55 -0.68 (-21.05%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$2.50 -0.05 (-2.04%)
As of 09/11/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Tenon Medical stock logo

Tenon Medical NASDAQ:TNON

$5.93 +0.63 (+11.89%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$5.44 -0.49 (-8.23%)
As of 09/11/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Vivos Therapeutics stock logo

Vivos Therapeutics NASDAQ:VVOS

$0.18 0.00 (-0.88%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$0.18 0.00 (-0.56%)
As of 09/11/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas